With the Commission's Decisions in Lundbeck, Johnson & Johnson and Servier, reverse payments in the pharmaceutical sector have recently come into EU Competition Policy's focus. On the other side of the Atlantic, instead, the decennial jurisprudential debate seems to have arrived at a turning...

Corona-Gesundheitsschock – Seuchengefahr für die Menschheit -- Weltweite Wirtschaftsinstabilität -- Risiko der Euro-Zerfallsdynamik und EU-Aspekte -- Impfförderungsaufgaben und Kooperation sowie globale Führungsfragen.

This paper investigates determinants of convergence in GDP per capita in the euro area and the EU between 1995 and 2021. It finds that the COVID-19 crisis temporarily slowed convergence but the estimated negative impact is significantly smaller than during the global financial crisis. Diverging...